Search Results

There are 5774 results for: content related to: A randomized phase 2 study of temozolomide and bevacizumab or nab -paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma

  1. You have free access to this content
    Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?

    Cancer

    Volume 119, Issue 3, 1 February 2013, Pages: 477–480, Kevin B. Kim

    Article first published online : 22 AUG 2012, DOI: 10.1002/cncr.27756

  2. Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane®) by the Pediatric Preclinical Testing Program (PPTP)

    Pediatric Blood & Cancer

    Volume 62, Issue 7, July 2015, Pages: 1214–1221, Peter J. Houghton, Raushan T. Kurmasheva, E. Anders Kolb, Richard Gorlick, John M. Maris, Jianrong Wu, Zeen Tong, Michael A. Arnold, Moumita Chatterjee, Terence M. Williams and Malcolm A. Smith

    Article first published online : 23 MAR 2015, DOI: 10.1002/pbc.25474

  3. Albumin-Drug Nanoparticles

    Drug Delivery in Oncology: From Basic Research to Cancer Therapy

    Felix Kratz, Peter Senter, Henning Steinhagen, Pages: 1133–1161, 2011

    Published Online : 16 DEC 2011, DOI: 10.1002/9783527634057.ch35

  4. You have free access to this content
    Interventions for preventing neuropathy caused by cisplatin and related compounds

    Intervention Review

    The Cochrane Library

    James W Albers, Vinay Chaudhry, Guido Cavaletti and Ross C Donehower

    Published Online : 31 MAR 2014, DOI: 10.1002/14651858.CD005228.pub4

  5. You have free access to this content
    A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck

    Cancer

    Volume 119, Issue 4, 15 February 2013, Pages: 766–773, Douglas Adkins, Jessica Ley, Kathryn Trinkaus, Wade Thorstad, James Lewis Jr, Tanya Wildes, Barry A. Siegel, Farrokh Dehdashti, Hiram Gay, Paul Mehan and Brian Nussenbaum

    Article first published online : 18 SEP 2012, DOI: 10.1002/cncr.27741

  6. You have full text access to this OnlineOpen article
    Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer

    Cancer Science

    Junji Tsurutani, Katsumasa Kuroi, Tsutomu Iwasa, Masaki Miyazaki, Shinichi Nishina, Chihiro Makimura, Junko Tanizaki, Kunio Okamoto, Toshinari Yamashita, Tomoyuki Aruga, Takashi Shigekawa, Yoshifumi Komoike, Toshiaki Saeki and Kazuhiko Nakagawa

    Article first published online : 9 APR 2015, DOI: 10.1111/cas.12658

  7. You have full text access to this OnlineOpen article
    Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel

    The Journal of Clinical Pharmacology

    Volume 54, Issue 10, October 2014, Pages: 1097–1107, Nianhang Chen, Yan Li, Ying Ye, Maria Palmisano, Rajesh Chopra and Simon Zhou

    Article first published online : 9 APR 2014, DOI: 10.1002/jcph.304

  8. You have full text access to this OnlineOpen article
    Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer

    Cancer Science

    Volume 105, Issue 7, July 2014, Pages: 812–817, Yasutsuna Sasaki, Tomohiro Nishina, Hirofumi Yasui, Masahiro Goto, Kei Muro, Akihito Tsuji, Wasaburo Koizumi, Yasushi Toh, Takuo Hara and Yoshinori Miyata

    Article first published online : 6 JUL 2014, DOI: 10.1111/cas.12419

  9. You have free access to this content
    Superior efficacy of a Cremophor-free albumin-bound paclitaxel compared with solvent-based paclitaxel in Chinese patients with metastatic breast cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 5, Issue 3, September 2009, Pages: 165–174, Zhong-Zhen GUAN, Qing Li LI, Fengyi FENG, Zefei JIANG, Zhenzhou SHEN, Shiying YU, Jifeng FEN, Jianjin HUANG, Zhiwen YAO and Paul BHAR

    Article first published online : 11 SEP 2009, DOI: 10.1111/j.1743-7563.2009.01235.x

    Corrected by:

    Erratum

    Vol. 6, Issue 1, 74, Article first published online: 8 MAR 2010

  10. Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors

    Cancer

    Volume 121, Issue 11, June 1, 2015, Pages: 1817–1826, Maysa M. Abu-Khalaf, Megan A. Baumgart, Scott N. Gettinger, Indukala Doddamane, David P. Tuck, Shihe Hou, Nianhang Chen, Catherine Sullivan, Kimberly Lezon-Geyda, Daniel Zelterman, Christos Hatzis, Hari Deshpande, Michael P. Digiovanna, Masoud Azodi, Peter E. Schwartz and Lyndsay N. Harris

    Article first published online : 3 FEB 2015, DOI: 10.1002/cncr.29254

  11. You have free access to this content
    Side effects of systemic oncological therapies in dermatology

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 10, Issue 7, July 2012, Pages: 475–486, Lisa Zimmer, Julia Vaubel, Elisabeth Livingstone and Dirk Schadendorf

    Article first published online : 9 MAY 2012, DOI: 10.1111/j.1610-0387.2012.07942.x

  12. You have free access to this content
    Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma

    Cancer

    Volume 115, Issue 1, 1 January 2009, Pages: 119–127, Domingo G. Perez, Vera J. Suman, Tom R. Fitch, Thomas Amatruda III, Roscoe F. Morton, Shamim Z. Jilani, Costas L. Constantinou, James R. Egner, Lisa A. Kottschade and Svetomir N. Markovic

    Article first published online : 17 DEC 2008, DOI: 10.1002/cncr.23987

  13. You have free access to this content
    Nab-Paclitaxel: a bright new SPARC in taxane therapy of cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 5, Issue 3, September 2009, Pages: 147–150, Stephen P Ackland, James M Bull and Frances M Boyle

    Article first published online : 11 SEP 2009, DOI: 10.1111/j.1743-7563.2009.01233.x

  14. You have full text access to this OnlineOpen article
    Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck

    Cancer Medicine

    Volume 4, Issue 4, April 2015, Pages: 481–489, Amy Schell, Jessica Ley, Ningying Wu, Kathryn Trinkaus, Tanya Marya Wildes, Loren Michel, Wade Thorstad, Hiram Gay, James Lewis, Jason Rich, Jason Diaz, Randal C. Paniello, Brian Nussenbaum and Douglas R. Adkins

    Article first published online : 26 JAN 2015, DOI: 10.1002/cam4.382

  15. You have free access to this content
    A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma

    Cancer

    Volume 117, Issue 8, 15 April 2011, Pages: 1704–1710, Lisa A. Kottschade, Vera J. Suman, Thomas Amatruda III, Robert R. McWilliams, Bassam I. Mattar, Daniel A. Nikcevich, Robert Behrens, Tom R. Fitch, Anthony J. Jaslowski and Svetomir N. Markovic

    Article first published online : 8 NOV 2010, DOI: 10.1002/cncr.25659

  16. Advances in the Treatment of Breast Cancer

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 1, January 2008, Pages: 26–36, S Moulder and G N Hortobagyi

    Article first published online : 19 DEC 2007, DOI: 10.1038/sj.clpt.6100449

  17. You have full text access to this OnlineOpen article
    Pancreatic cancer and FOLFIRINOX: a new era and new questions

    Cancer Medicine

    Robert De W. Marsh, Mark S. Talamonti, Matthew Harold Katz and Joseph M. Herman

    Article first published online : 19 FEB 2015, DOI: 10.1002/cam4.433

  18. You have free access to this content
    Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204

    Cancer

    Volume 119, Issue 8, 15 April 2013, Pages: 1521–1527, Jerome C. Landry, Yang Feng, Steven J. Cohen, Charles A. Staley III, Richard Whittington, Elin Ruth Sigurdson, Halla Nimeiri, Udit Verma, Roshan S. Prabhu and Al Bowen Benson

    Article first published online : 3 JAN 2013, DOI: 10.1002/cncr.27890

  19. You have full text access to this Open Access content
    Complete remission and fatal interstitial pneumonitis related to nab-paclitaxel in refractory small cell lung cancer: A case report and review of the literature

    Thoracic Cancer

    Volume 3, Issue 1, February 2012, Pages: 84–87, Binchao Wang, Jinji Yang, Donglan Luo, Huixian Qiao, Zhi Xie, Xuchao Zhang and Yilong Wu

    Article first published online : 5 FEB 2012, DOI: 10.1111/j.1759-7714.2011.00086.x

  20. Systemic Paclitaxel for Prevention of Restenosis

    Pharmacology in the Catheterization Laboratory

    Ron Waksman, Andrew E. Ajani, Pages: 321–327, 2009

    Published Online : 30 OCT 2009, DOI: 10.1002/9781444306347.ch41